Dr. Jack West summarizes the rationale for testing immune checkpoint inhibitors as a first line treatment for patients with advanced NSCLC and highlights details of two trials testing this question.
Clinical Trials of Immune Checkpoint Inhibitors as First Line Therapy for Advanced NSCLC [360p]
